Home > PJ (current issue) > News / Daily News | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 269 No 7219 p513-518
12 October 2002


News summary

Branch meetings   Future Events   Conferences  

Repeat dispensing pathfinder sites announced; remuneration not agreed Thirty proposed pathfinder sites for pharmacy-based National Health Service repeat dispensing have been named by the Department of Health...[more]

Cancer survival estimates too low Conventional estimates for life expectancy after cancer diagnosis have been too pessimistic, say researchers...[more]

Scottish heart and stroke plan launched Scotland's first strategy to combat heart disease and stroke has set a target to halve deaths from coronary heart disease (CHD) and stroke among Scots aged under 75 years by 2010...[more]

Supervisors of the health professions must have no record of misconduct Rules governing the appointment of members of the Council for the Regulation of Health Care Professionals (CRHCP) preclude the appointment of anyone who has ever been guilty of professional misconduct...[more]

NOS primary care osteoporosis strategy published The role that pharmacists and other primary care staff can play in preventing osteoporotic fractures and falls has been outlined in a new National Osteoporosis Society strategy document...[more]

Pharmacists can help drug misusers benefit from integrated care The role of community and hospital pharmacists in the integrated care of drug misusers has been highlighted in a new Scottish Executive report...[more]

Skill mix proposals may weaken the medicines safety net, warns the NPA A warning that proposals in the Department of Health’s pharmacy workforce discussion document could reduce patient safety has been voiced by the National Pharmaceutical Association...[more]

MeReC — statins, HRT and etanercept The Heart Protection Study supports the practice of targeting patients based on their absolute risk of suffering a cardiovascular event and indicates that statins should be an option for all high-risk patients, the latest issue of MeReC Extra states...[more]

Conflict between concordance and NSFs to be research subject Research at the University of Leeds is to examine the potential conflict between partnership in medicine taking (concordance) and top-down prescribing pressures...[more]

Government rejects calls for major changes to the NICE appeals system Calls from the House of Commons Health Select Committee and the pharmaceutical industry for changes to the National Institute for Clinical Excellence's appeals procedure have been largely rejected by the Government...[more]

Long-term, high-dose rofecoxib should be avoided Patients who start rofecoxib (Vioxx) treatment at a high dose (>25mg daily) could be at almost twice the risk of serious coronary heart disease (CHD) compared with patients who do not use non-steroidal anti-inflammatory drugs, say American researchers...[more]

Memantine launched for treatment of Alzheimer's MEMANTINE (Ebixa) — an N-methyl-D-aspartate (NMDA) receptor antagonist launched this week in the United Kingdom — continues to provide benefits to patients with Alzheimer's disease (AD) after one year, researchers report...[more]

Cisplatin-based chemotherapy should be first-line treatment for lung cancer Patients with lung cancer who are treated with cisplatin and paclitaxel have better survival rates than patients treated with carboplatin and paclitaxel, results of a European trial suggest...[more]

Evidence that ACE inhibition is affected by aspirin is weak Concomitant use of aspirin and angiotensin-converting enzyme (ACE) inhibitors should be considered in all patients at high risk of major vascular events, say researchers...[more]

Tacrolimus ointment better than topical steroids in atopic dermatitis TACROLIMUS ointment (Protopic), a topical immunomodulator, changes the course of moderate to severe atopic dermatitis by reducing the severity and frequency of flare-ups, according to a long-term trial reported earlier this month at the 11th Congress of the European Academy of Dermatology and Venereology in Prague...[more]

Breast cancer risk higher for teenage smokers Women who smoke in their teens increase their risk of developing breast cancer later in life, Canadian researchers suggest...[more]

Medicines not to blame for smaller brain size of children with ADHD The smaller brain size of children with attention-deficit hyperactivity disorder (ADHD) is not caused by drug treatment, a new study suggests...[more]

Under-age sex and STI risk Girls under 16 years of age attending a London genitourinary clinic with a suspected sexually transmitted infection (STI) were found to be three times more likely to have an STI compared with other women...[more]

SIDS risk confirmed Sleeping on the stomach increases the risk of sudden infant death syndrome (SIDS), American researchers have confirmed...[more]

Paracetamol poisoning Using a mouse bred to lack constitutive androstane receptors (CAR), researchers have shown that this protein is critical to the toxicity of paracetamol...[more]

Lloyds launches CD-ROM Lloydspharmacy has launched a continuing professional development CD-ROM for its pharmacists...[more]

Exercise slows functional decline Exercise can reduce the progression of functional decline among physically frail, older people, say researchers...[more]

GP practice teacher-practitioner...[more]

Patients want records protected...[more]

Malaria parasite genome cracked...[more]

Back to Top

  * PDF files on PJ Online require Acrobat Reader 4 or later.


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal